» Articles » PMID: 29263404

Identifying the Ubiquitination Targets of E6AP by Orthogonal Ubiquitin Transfer

Overview
Journal Nat Commun
Specialty Biology
Date 2017 Dec 22
PMID 29263404
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

E3 ubiquitin (UB) ligases are the ending modules of the E1-E2-E3 cascades that transfer UB to cellular proteins and regulate their biological functions. Identifying the substrates of an E3 holds the key to elucidate its role in cell regulation. Here, we construct an orthogonal UB transfer (OUT) cascade to identify the substrates of E6AP, a HECT E3 also known as Ube3a that is implicated in cancer and neurodevelopmental disorders. We use yeast cell surface display to engineer E6AP to exclusively transfer an affinity-tagged UB variant (xUB) to its substrate proteins. Proteomic identification of xUB-conjugated proteins in HEK293 cells affords 130 potential E6AP targets. Among them, we verify that MAPK1, CDK1, CDK4, PRMT5, β-catenin, and UbxD8 are directly ubiquitinated by E6AP in vitro and in the cell. Our work establishes OUT as an efficient platform to profile E3 substrates and reveal the cellular circuits mediated by the E3 enzymes.

Citing Articles

A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins.

Ganesan I, Kiyokawa H Cancers (Basel). 2025; 17(4).

PMID: 40002221 PMC: 11853300. DOI: 10.3390/cancers17040626.


SelK promotes glioblastoma cell proliferation by inhibiting β-TrCP1 mediated ubiquitin-dependent degradation of CDK4.

Li J, Zhao L, Wu Z, Huang S, Wang J, Chang Y J Exp Clin Cancer Res. 2024; 43(1):231.

PMID: 39155374 PMC: 11331741. DOI: 10.1186/s13046-024-03157-x.


Neuronal UBE3A substrates hold therapeutic potential for Angelman syndrome.

Krzeski J, Judson M, Philpot B Curr Opin Neurobiol. 2024; 88:102899.

PMID: 39126903 PMC: 11397222. DOI: 10.1016/j.conb.2024.102899.


A ubiquitin-specific, proximity-based labeling approach for the identification of ubiquitin ligase substrates.

Mukhopadhyay U, Levantovsky S, Carusone T, Gharbi S, Stein F, Behrends C Sci Adv. 2024; 10(32):eadp3000.

PMID: 39121224 PMC: 11313854. DOI: 10.1126/sciadv.adp3000.


CDKL3 is a targetable regulator of cell cycle progression in cancers.

Zhang H, Lin J, Zheng S, Ma L, Pang Z, Yin H J Clin Invest. 2024; 134(16).

PMID: 38963708 PMC: 11324297. DOI: 10.1172/JCI178428.


References
1.
Maspero E, Valentini E, Mari S, Cecatiello V, Soffientini P, Pasqualato S . Structure of a ubiquitin-loaded HECT ligase reveals the molecular basis for catalytic priming. Nat Struct Mol Biol. 2013; 20(6):696-701. DOI: 10.1038/nsmb.2566. View

2.
Zhao B, Bhuripanyo K, Zhang K, Kiyokawa H, Schindelin H, Yin J . Orthogonal ubiquitin transfer through engineered E1-E2 cascades for protein ubiquitination. Chem Biol. 2012; 19(10):1265-77. PMC: 4104569. DOI: 10.1016/j.chembiol.2012.07.023. View

3.
Glessner J, Wang K, Cai G, Korvatska O, Kim C, Wood S . Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009; 459(7246):569-73. PMC: 2925224. DOI: 10.1038/nature07953. View

4.
Merbl Y, Kirschner M . Large-scale detection of ubiquitination substrates using cell extracts and protein microarrays. Proc Natl Acad Sci U S A. 2009; 106(8):2543-8. PMC: 2633216. DOI: 10.1073/pnas.0812892106. View

5.
Tan M, Lim H, Bennett E, Shi Y, Harper J . Parallel SCF adaptor capture proteomics reveals a role for SCFFBXL17 in NRF2 activation via BACH1 repressor turnover. Mol Cell. 2013; 52(1):9-24. PMC: 3981468. DOI: 10.1016/j.molcel.2013.08.018. View